SPLENECTOMY IN HEMATOLOGIC DISEASES
article
OA: closed
CC0
AI-generated summary
Splenectomy achieved lasting remission in 75% of idiopathic thrombocytopenic purpura, all hereditary spherocytosis patients, and over 50% with acquired hemolytic anemia, but not hereditary non-spherocytic hemolytic anemia.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Abstract The effect of splenectomy in a variety of hematological disorders has been evaluated by a follow‐up study of 179 patients 3–15 years after surgery. A lasting remission was obtained in about 75% of patients with idiopathic thrombocytopenic purpura. All patients with hereditary spherocytosis had a complete remission, whereas hereditary non‐spherocytic hemolytic anemia was not influenced by splenectomy. More than 50% of patients with acquired hemolytic anemia showed no symptoms of hemolytic disease when examined ten years after surgery. Twenty‐five % of the patients with pancytopenia were in good condition ten years after splenectomy. Normal or increased bone marrow cellularity in this condition strengthens the indication for surgery. The proliferative diseases including chronic lymphatic leukemia, lymphosarcoma and myelofibrosis may represent indications for surgery whereas chronic myelogenous leukemia seemed to be a contraindication for splenectomy. The hematological disturbances associated with congestive splenomegaly usually can be corrected by splenectomy.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (23)
- doi:10.1097/00000658-195710000-00011 via openalex
- doi:10.1002/1097-0142(196604)19:4<461::aid-cncr2820190402>3.0.co;2-x via openalex
- doi:10.1182/blood.v14.12.1280.1280 via openalex
- doi:10.1097/00000441-196206000-00001 via openalex
- doi:10.1097/00005792-195905000-00003 via openalex
- doi:10.1016/s0025-7125(16)33103-0 via openalex
- doi:10.7326/0003-4819-58-2-259 via openalex
- doi:10.1097/00000658-196405000-00007 via openalex
- doi:10.1111/j.0954-6820.1964.tb00605.x via openalex
- W1723328258 via openalex
- W1925243021 via openalex
- W2167192577 via openalex
- W2394611823 via openalex
- W6640253377 via openalex
- doi:10.1001/jama.1959.03010320001001 via openalex
- doi:10.1001/jama.1937.02780410008003 via openalex
- doi:10.1056/nejm196606022742207 via openalex
- doi:10.1097/00000658-196305000-00008 via openalex
- doi:10.7326/0003-4819-39-3-651_1 via openalex
- doi:10.1182/blood.v9.10.986.986 via openalex
- doi:10.1056/nejm196606092742306 via openalex
- doi:10.1093/oxfordjournals.qjmed.a067082 via openalex
- doi:10.1056/nejm196609222751202 via openalex
Source provenance
- openalex
- last seen: 2026-05-10T11:20:10.739872+00:00
- unpaywall
- last seen: 2026-08-01T06:38:12.426807+00:00
License: CC0
· commercial use OK